Biocon Biologics partners with Sandoz for distribution of its biosimilar to treat immune-related diseases in Japan
时间:2024-06-29 01:53:18 阅读(143)
Biocon Biologics Ltd on Friday signed a Distribution Agreement with Sandoz, granting the Company the exclusive rights to promote, sell and distribute th injection of Adalimumab BS in Japan.
“Based on this Agreement, Viatris has completed marketing and promotion of the product as of December 15, 2023, but will continue to provide transition support until Sandoz will gradually assume responsibilities for the product starting February 15, 2024. Biocon Biologics has acquired the global biosimilars portfolio of Viatris including Adalimumab. Fujifilm Kyowa Kirin Biologics Co. Ltd., the developer of the drug, has concluded an exclusive global marketing license agreement with Biocon Biologics Ltd affiliate,” the company said in a statement.
“Sandoz is committed to further strengthening its product pipeline to drive sustainable business growth,” it added.
The transfer of the distribution rights of this product is part of this strategy, and its addition to the product portfolio will strengthen Sandoz’s immunology and biosimilar portfolio.
Biocon Biologics recently announced the successful completion of its integration of the acquired Viatris’ biosimilars business in 120 countries ahead of schedule, marking a significant milestone in the Company’s journey as a fully integrated, global biosimilars enterprise. At a global level, Biocon Biologics has a robust pipeline of 20 assets for diabetology, oncology, immunology, and ophthalmology.
猜你喜欢
- Reliance Power offers Rs 1,200 cr to settle debt of Butibori power project
- Revolutionising coaching and mentoring with Generative AI in 2024
- Reliance Industries Rating- overweight; Tax rate, depreciation hit earnings
- Yes Bank, IndusInd Bank, Adani Wilmar, Reliance, HUL, HDFC Life, Oil India stocks in focus on 19 July 2022
- Reliance, Infosys, Yes Bank, Axis Bank, Zomato, Usha Martin, Network18 stocks in focus on weekly F&O expiry
- Reliance stock in top gear, nears its lifetime highs
- Reliance, SpiceJet, Infosys, Cipla, Tata Motors, Dish TV, ONGC, Zee Ent stocks in focus on F&O expiry
- WPP is said to weigh options for 40% stake in Bain’s Kantar
- Reliance, ITC, IDBI Bank, Hindustan Zinc, RBL Bank, PVR, HDFC AMC, UltraTech Cement stocks in focus on 22 July